A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity

Clinical trial NCT07310563 · COMPLETED

Trial details

NCT number: NCT07310563
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2024-12-10
Primary completion: 2025-05-09
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.